US Adds Atlanta Area Airport for Ebola Screening, CDC Says

Published Date: 27 May 2026

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

Read Full News

Latest News

US to Provide $50 Million More in Funding to Counter Ebola Outbreak

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

EMA Curbs Chikungunya Jab After Serious Safety Review

European regulators have restricted the chikungunya vaccine Ixchiq after serious adverse events, including neurologic events and deaths, were reported in both older and younger adults.

Congo Says 782 Ebola Cases Confirmed, Two New Health Zones Affected

The number of confirmed Ebola cases in ⁠Democratic Republic of Congo has increased to 782 after 72 ⁠new cases were documented in 24 hours, one ⁠of the biggest ‌single-day...

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Funding Cuts Drive Sharp Drop in HIV Prevention, UNAIDS Says

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

European regulators have restricted the chikungunya vaccine Ixchiq after serious adverse events, including neurologic events and deaths, were reported in both older and younger adults.

The number of confirmed Ebola cases in ⁠Democratic Republic of Congo has increased to 782 after 72 ⁠new cases were documented in 24 hours, one ⁠of the biggest ‌single-day...

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

News All Time

Romania Remains Europe’s Measles Hotspot

Romania’s children under 5 are experiencing the worst of Europe’s measles outbreaks. Are new policies sufficient to encourage more childhood vaccinations?

WHO Launches $518 Million Plan to Curb Africa Ebola Outbreak

The World Health Organization chief announced a $518 million six-month joint plan to fight Ebola on Friday, calling ⁠for money and political commitment to halt the spread of...

WHO Says Ebola Response Catching Up as Confirmed DRC Cases Hit 344

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

Deep Dive: IL Inhibitor and JAK Inhibitor in Atopic Dermatitis

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

US to Re-engage With Gavi Vaccine Alliance Amid Ebola Outbreak, Rubio Says

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

Deep Dive: Reducing CV Risk Beyond LDL in Secondary Prevention

The 2026 ACC/AHA Dyslipidemia Guideline has set a numerical LDL-C target for secondary prevention. Now what?

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

FDA Advisers Recommend COVID Vaccines Be Updated to Target Current Dominant Variant

The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target ⁠the dominant XFG variant, despite some...

Medicine Renamed Many Diseases: Why Rename PCOS?

The proposed PMOS terminology reframes PCOS by emphasizing the psychological, dermatologic, reproductive, and metabolic features linked to the condition.

US CDC Seeks Staff for Ebola Screening as Outbreak Response Expands

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

mRNA Shot Offers Efficacy for Influenza-Like Illness

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

US FDA Advisers to Weigh Updating 2026-27 COVID Vaccines for XFG Variant

Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG ⁠subvariant for the 2026-27...

Recommended News For You

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

Best foot forward—chemo care should include podiatry, say researchers

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

June 20, 2023, Health Bulletin No. 12.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

Recommended Articles For You

The Mysterious World of Petechiae: Exploring Causes and Treatments 

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances 

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Video: How to treat kidney disease?

2.

DNA origami offers more accurate imaging in the fight against pancreatic cancer

3.

After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

4.

How to keep your prostate healthy and lower your risk of developing serious problems

5.

Why alarm is easing over a rise in pancreatic cancer among the young

1.

Clinical Methods in Hematology and Quality Improvement

2.

Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease

3.

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion

4.

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome

5.

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot